Calling for extended collaboration in Biotech StartUps and Vaccine Development with Public Private Partnership for Global Good, Union Minister Jitendra Singh has said that India is fast emerging as the world's major bio-economy and over the last few years, it has grown by leaps and bounds when it comes to innovation and technology.
The Minister added that the Department of Biotechnology (DBT) in Ministry of Science & Technology has through ‘Mission COVID Suraksha’, delivered four vaccines, augmented the manufacturing of Covaxin, and created necessary infrastructure for smooth development of future vaccines, so that the country is pandemic ready.
Singh further underlined that the Indian vaccine market, which has carved out a place for itself at the global level, is expected to reach a valuation of Rs 252 billion by 2025. The Minister also pointed out that recently, DBT signed a tripartite MoU with Indian Council of Medical Research (ICMR) and IAVI on February, 24, 2022 for a period of five years.
